Keyphrases
Rheumatoid Arthritis
100%
Tumour Necrosis Factor Inhibitor (TNFi)
68%
Axial Spondyloarthritis (AxSpA)
45%
DANBIO Registry
45%
Rheumatoid Arthritis Patients
43%
Routine Care
43%
Clinical Remission
38%
Clinical Practice
38%
Radiographic Progression
36%
Magnetic Resonance Imaging
34%
Treatment Response
31%
Inflammation
27%
Biologic DMARDs
27%
Drug Survival
27%
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
26%
Disease Activity
23%
C-reactive Protein
21%
Ankylosing Spondylitis Disease Activity Score (ASDAS)
20%
Adalimumab
20%
Infliximab
19%
Inhibitor Therapy
18%
Cartilage Turnover
18%
Inflammatory Biomarkers
18%
Bone Turnover
18%
Global Rankings
16%
Inhibitor Treatment
15%
Rheumatologists
14%
2-year Follow-up
14%
Clinical Outcomes
14%
Ultrasound
14%
Remission
14%
TNF Inhibitors
13%
Clinical Response
13%
Angiogenesis
13%
Glucocorticoid Therapy
13%
Methotrexate
13%
Outpatient Clinic
12%
Disease Activity Score 28 (DAS28)
12%
Treatment Drugs
11%
Prednisolone
11%
Odds Ratio
11%
Radiography
10%
Clinical Practice Guidelines
10%
Bone Erosion
10%
Incidence Rate
10%
Scoring System
10%
Etanercept
10%
Disease Activity Score
9%
Synovitis
9%
Outpatient Follow-up
9%
Medicine and Dentistry
Rheumatoid Arthritis
63%
TNF Inhibitor
47%
Magnetic Resonance Imaging
43%
Echography
27%
Biological Marker
27%
Spondylarthritis
27%
BASDAI
22%
Treatment Response
22%
C Reactive Protein
19%
Bone Turnover
18%
Telopeptide
13%
Carboxy Terminal Sequence
13%
Angiogenesis
13%
Cross-Link
13%
Outpatient
12%
Adalimumab
11%
Ankylosing Spondylitis Disease Activity Score
11%
Cohort Analysis
11%
Infliximab
10%
Disease Activity
10%
Bone Erosion
10%
Randomized Controlled Trial
9%
Disease Activity Score
9%
Positron Emission Tomography
9%
Fluorodeoxyglucose
9%
Scoring System
9%
Diagnosis
9%
Drug Response
9%
Psoriatic Arthritis
9%
Patient-Reported Outcome
9%
Computer Assisted Tomography
9%
Glucocorticoid
9%
Drug Dose Regimen
9%
Polymyalgia Rheumatica
9%
Computed Radiography
9%
Cardiovascular Agent
9%
Collagen Type 2
9%
Fragility Fracture
9%
Osteocalcin
9%
Ankylosing Spondylitis
9%
Vasculotropin
9%
Interleukin 6
9%
Cartilage Oligomeric Matrix Protein
9%
Digoxin
9%
Thiazide Diuretic Agent
9%
Furosemide
9%
Aggrecan
9%
Stromelysin
9%
Tumor Necrosis Factor
7%
DAS28
6%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
72%
Tumor Necrosis Factor Inhibitor
42%
Inflammation
28%
Remission
28%
Adalimumab
20%
Infliximab
19%
Disease
18%
Disease Activity Score
15%
Cohort Study
14%
Glucocorticoid
14%
Methotrexate
13%
Prednisolone
12%
Etanercept
10%
Adrenal Insufficiency
9%
Biological Marker
9%
Comorbidity
9%
Thiazide Diuretic Agent
9%
Immunoglobulin M
9%
Psoriatic Arthritis
9%
Spondylarthritis
9%
Fluorodeoxyglucose
9%
Fragility Fracture
9%
C Reactive Protein
9%
Rheumatic Polymyalgia
9%
Furosemide
9%
Cardiovascular Agent
9%
Digoxin
9%
Mouse Model
9%
Mannan Binding Lectin
9%
Serine Proteinase
9%
Proximal Humerus Fracture
7%
Tumor Necrosis Factor
7%
Disease Activity
7%
Arthritis
5%
